Patient Blood Management Market
Patient Blood Management Market Size Analysis, By Product (Instruments, Accessories, Reagents & Kits, Software), By Component (Whole Blood & Red Blood Cells, Plasma), By End User (Hospitals, Blood Banks, Diagnostic Clinics, Pathology Labs) - Global Market Insights 2022 to 2027
Analysis of Patient Blood Management market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Patient Blood Management Market Outlook (2022 to 2027)
The global patient blood management market in 2022 is valued at US$ 12.7 billion and is estimated to reach a sales revenue of US$ 18.4 billion by the end of 2027. Demand for patient blood management is anticipated to increase rapidly at a CAGR of 7.7% over the next five years.
The market is expected to be primarily driven by the high prevalence of blood-related disorders and also the growing number of blood donors across the world. Increasing investments in healthcare infrastructure development in emerging economies, rising technological proliferation in the healthcare sector, high prevalence of blood disorders, and technological advancements in patient blood management devices are other factors that are set to uplift market growth potential over the coming years.
- As per data from the World Health Organization (WHO), an increase of 10.7 million voluntary unpaid blood donations has been reported in the period 2008 to 2018. Of which, the highest increase of around 127% was recorded in the Southeast Asia region, followed by the American region with an increase of around 81%.
An increasing number of blood banks owing to the rising number of blood donors is also a prime factor that is predicted to supplement the patient blood management market evolution. Growing focus on healthcare cost reduction is also expected to drive the demand for patient blood management (PBM).
Growing demand for plasma-derived medicinal products (PDMP) across the world is also expected to promote the adoption of blood storage and management systems across the world. Rising number of accidents across the world is also expected to contribute to the rising demand for efficient patient blood management solutions that help in acquiring the needed blood in times of emergency. Increasing focus on patient safety is also expected to promulgate the deployment of patient blood management software in healthcare institutions to reduce complications and medical costs.
Corruption and stocking of blood in blood banks to gain monetary benefits are major challenges that could negatively impact the patient blood management market share in the near future. Also, the high costs of patient blood management systems and software are expected to have a constraining effect on overall market development throughout the forecast period.
Demand for blood management in China is anticipated to increase at an impressive CAGR of 10% throughout the forecast period and account for a revenue of US$ 3.8 billion by the end of 2027. Supportive government initiatives to develop healthcare infrastructure are expected to play a major role in the development of the market in China over the coming years.
A complete analysis of all market trends, opportunities, challenges, and restraints has been profiled in this latest patient blood management market report by skilled analysts at Fact.MR, a market research and competitive intelligence provider.
| Report Attributes | Details |
|---|---|
| Patient Blood Management Market Size (2022) | US$ 12.7 Billion |
| Projected Market Value (2027F) | US$ 18.4 Billion |
| Global Market Growth Rate (2022 to 2027) | 7.7% CAGR |
| United States Market Value (2022) | US$ 3.5 Billion |
| Software Segment Growth Rate (2022 to 2027) | 6.3% CAGR |
| Canada Market Growth Rate (2022 to 2027) | 6.1% CAGR |
| China Market Value (2027F) | US$ 3.8 Billion |
| Key Companies Profiled | Macopharma; Biomérieux SA; F. Hoffmann-La Roche LTD.; Terumo Corporation; Asahi Kasei Medical Co. Ltd.; Immucor Inc.; Kaneka Corporation; Abbott Laboratories; Grifols S.A.; Bio-Rad Laboratories Inc.; Fresenius Se & Co. KGaA; Haemonetics Corporation; Livanova PLC; B. Braun Melsungen AG |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Aspects are Expected to Guide Patient Blood Management Market Development?
“Rising Number of Blood Donors Will Uplift Demand for Patient Blood Management Systems”
Blood donations across the world have increased substantially in recent years owing to rising demand for blood transfusions while treating several chronic diseases that are expected to rise across the forecast period. Increasing use of donated blood in the treatment of several diseases is anticipated to supplement patient blood management market growth throughout the forecast period.
“Growing Demand for Reduction of Healthcare Costs”
While the focus on healthcare has bolstered exponentially in the past few years there has also been a substantial increase in the overall cost of healthcare. Patient blood management can be used to mitigate this issue by eliminating the need for allogeneic blood transfusions. Patient blood management also helps in the conservation of patients’ blood during medical procedures and reduces the overall need for blood and hence reducing medical costs.
Patient blood management also helps in reducing complications by avoiding blood loss and keeping the patient safe and stable while undergoing a medical procedure or in recovery.
“Cost of Patient Blood Management Devices Need to Be Reduced”
Patient blood management requires software and hardware components that are expensive in nature most of the time and this results in highly-priced blood management equipment. Many healthcare establishments don’t have the budget to afford such expensive equipment and this acts as a major restraint for overall patient blood management market growth.
High costs of blood transfusion devices and whole blood units also contribute to the high costs of blood transfusion processes and hence have a negative impact on demand for patient blood management.
Which Regional Market Should Patient Blood Management Providers Focus On More?
“Asia Pacific Expected to Witness Upsurge in Product & Service Demand”
The patient blood management market in North America currently holds a dominant market stance and is expected to maintain a similar position throughout the forecast period. Developed healthcare infrastructure in this region is anticipated to be a prime driver for patient blood management market potential over the years to come. The rapid adoption of advanced healthcare technologies in this region is also expected to be a key driver for the market in North America through 2027.
The market for patient blood management in Canada is projected to evolve at a healthy CAGR of 6.1% over the next five years.
The Asia Pacific patient blood management market is anticipated to be the most lucrative market across the forecast period owing to increasing investments in healthcare infrastructure development and supportive initiatives from governments in this region. Rising awareness for blood transfusions, the growing availability of blood management devices, technological advancements, an increasing patient pool requiring blood management, and a high incidence of chronic diseases are other factors that sculpt patient blood management market growth in this region.
Developing economies of India and China are expected to head the patient blood management market growth in this region over the years to come. The flourishing medical tourism industry in the aforementioned economies is also expected to provide new opportunities for patient blood management providers. The demand for patient blood management in Japan is predicted to increase at a 3.7% CAGR across the forecast period.
The growing geriatric patient pool and rising prevalence of blood disorders are expected to be prime drivers for the Europe patient blood management market in the future. Germany is predicted to be a crucial market in this region and is projected to evolve at a 4% CAGR over the next five years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
Why is Demand for Blood Processing Devices High in the U.S.?
“High Incidence of Blood Disorders & Presence of Developed Healthcare Infrastructure”
The United is the most lucrative market in the North American region owing to its developed healthcare infrastructure and rapid adoption of advanced healthcare technologies. The country has witnessed a notable increase in the incidence of blood-related disorders and blood cancer, which is expected to further boost demand for patient blood management.
As per statistics from the Community Blood Center, around 4.5 million Americans will be needing blood transfusions each year and around 37% population of the United States is eligible to donate blood.
Favorable reimbursement policies, high healthcare spending potential, and the presence of key patient blood management providers are other factors that favor patient blood management market growth in the United States. At present, the U.S. patient blood management market is valued at US$ 3.5 billion and is expected to account for a major revenue share in the North American market throughout the forecast period.
Category-wise Insights
Which Product Will Have a Bright Demand Outlook?
“Instruments & Software to Spearhead Patient Blood Management Market Evolution”
The global patient blood management market, based on product, is segmented into reagents & kits, software, accessories, and instruments.
Demand for instruments is anticipated to increase at a CAGR of 6.5% over the next five years owing to their increasing demand in hospitals and blood banks. A growing number of blood transfusions and rising demand for proper management of blood are other factors that are expected to drive growth in the instruments segment. The demand for software is slated to rise at a CAGR of 6.3% across the forecast period and this can be ascribed to the rising popularity of automated patient blood management systems.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape :
Major players operating in the patient blood management market are deploying strategies that could help them enhance their overall market share and bolster their stance on a global scale.
- In October 2022, InVita Healthcare Technologies, a leading software solution provider announced the acquisition of BloodHub, a leader in blood and biologics supply chain automation. Through this BloodHub with InVita's Blood Management Division is looking to become the most complete provider of connected software solutions for blood centers.
Patient Blood Management Industry Research Segments
-
By Product :
- Instruments
- Blood Processing Devices
- Centrifuges
- Blood Cell Processors
- Blood Transfusion Devices
- Apheresis Machines
- Plasma & Plasma Component Separators
- Cell Salvage Systems
- Others
- Blood Culture Screening Devices
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
- Diagnostic & Testing Instruments
- PCR Instruments
- Hematology Analyzers
- NGS Platforms
- Blood Grouping Analyzers
- Blood Storage Devices
- Medical Refrigerators
- Medical Freezers
- Blood Processing Devices
- Accessories
- Syringes & Needles
- Vials & Tubes
- Blood Bags
- Others
- Reagents & Kits
- Blood Culture Media
- Blood Typing Reagents
- Slide Staining Reagents
- Assay Kits
- Others
- Software
- Blood Bank Management Software
- Transfusion Management Software
- Others
- Instruments
-
By Component :
- Whole Blood & Red Blood Cells
- Plasma
-
By End User :
- Hospitals
- Diagnostic Clinics
- Blood Banks
- Pathology Labs
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, By Component
- 6.1. Whole Blood & Red Blood Cells
- 6.2. Plasma
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Product
- 7.1. Instruments
- 7.2. Accessories
- 7.3. Reagents & Kits
- 7.4. Software
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by End User
- 8.1. Hospitals
- 8.2. Diagnostic Clinics
- 8.3. Blood Banks
- 8.4. Pathology Labs
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Macopharma
- 17.2. Biomérieux SA
- 17.3. F. Hoffmann-La Roche LTD.
- 17.4. Terumo Corporation
- 17.5. Asahi Kasei Medical Co. Ltd.
- 17.6. Immucor Inc.
- 17.7. Kaneka Corporation
- 17.8. Abbott Laboratories
- 17.9. Grifols S.A.
- 17.10. Bio-Rad Laboratories Inc.
- 17.11. Fresenius Se & Co. KGaA
- 17.12. Haemonetics Corporation
- 17.13. Livanova PLC
- 17.14. B. Braun Melsungen AG
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Component, 2017 to 2021
Table 02: Global Market Value (US$ Mn) Analysis, by Component, 2022 to 2027
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2021
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022 to 2027
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2027
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 16: North America Market Value (US$ Mn) Analysis, by Component, 2017 to 2021
Table 17: North America Market Value (US$ Mn) Analysis, by Component, 2022 to 2027
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 28: Latin America Market Value (US$ Mn) Analysis, by Component, 2017 to 2021
Table 29: Latin America Market Value (US$ Mn) Analysis, by Component, 2022 to 2027
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 40: Europe Market Value (US$ Mn) Analysis, by Component, 2017 to 2021
Table 41: Europe Market Value (US$ Mn) Analysis, by Component, 2022 to 2027
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027
Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 52: East Asia Market Value (US$ Mn) Analysis, by Component, 2017 to 2021
Table 53: East Asia Market Value (US$ Mn) Analysis, by Component, 2022 to 2027
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Component, 2017 to 2021
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Component, 2022 to 2027
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 76: MEA Market Value (US$ Mn) Analysis, by Component, 2017 to 2021
Table 77: MEA Market Value (US$ Mn) Analysis, by Component, 2022 to 2027
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027
Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 04: Global Market Incremental $ Opportunity, 2022 to 2027
Figure 05: Global Market Share and BPS Analysis by Component, 2022 & 2027
Figure 06: Global Market Y-o-Y Growth Projections by Component, 2022 to 2027
Figure 07: Global Market Attractiveness Analysis by Component, 2022 to 2027
Figure 08: Global Market Share and BPS Analysis by Product, 2022 & 2027
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 10: Global Market Attractiveness Analysis by Product, 2022 to 2027
Figure 11: Global Market Share and BPS Analysis by End User, 2022 & 2027
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2027
Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2027
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2022 to 2027
Figure 20: North America Market Incremental $ Opportunity, 2022 to 2027
Figure 21: North America Market Share Analysis by Country, 2022 & 2027
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 24: North America Market Share and BPS Analysis by Component, 2022 & 2027
Figure 25: North America Market Y-o-Y Growth Projections by Component, 2022 to 2027
Figure 26: North America Market Attractiveness Analysis by Component, 2022 to 2027
Figure 27: North America Market Share and BPS Analysis by Product, 2022 & 2027
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 29: North America Market Attractiveness Analysis by Product, 2022 to 2027
Figure 30: North America Market Share and BPS Analysis by End User, 2022 & 2027
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 32: North America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2027
Figure 37: Latin America Market Share Analysis by Country, 2022 & 2027
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 40: Latin America Market Share and BPS Analysis by Component, 2022 & 2027
Figure 41: Latin America Market Y-o-Y Growth Projections by Component, 2022 to 2027
Figure 42: Latin America Market Attractiveness Analysis by Component, 2022 to 2027
Figure 43: Latin America Market Share and BPS Analysis by Product, 2022 & 2027
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 45: Latin America Market Attractiveness Analysis by Product, 2022 to 2027
Figure 46: Latin America Market Share and BPS Analysis by End User, 2022 & 2027
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 48: Latin America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2027
Figure 53: Europe Market Share Analysis by Country, 2022 & 2027
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2027
Figure 56: Europe Market Share and BPS Analysis by Component, 2022 & 2027
Figure 57: Europe Market Y-o-Y Growth Projections by Component, 2022 to 2027
Figure 58: Europe Market Attractiveness Analysis by Component, 2022 to 2027
Figure 59: Europe Market Share and BPS Analysis by Product, 2022 & 2027
Figure 60: Europe Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 61: Europe Market Attractiveness Analysis by Product, 2022 to 2027
Figure 62: Europe Market Share and BPS Analysis by End User, 2022 & 2027
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 64: Europe Market Attractiveness Analysis by End User, 2022 to 2027
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2027
Figure 69: East Asia Market Share Analysis by Country, 2022 & 2027
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 72: East Asia Market Share and BPS Analysis by Component, 2022 & 2027
Figure 73: East Asia Market Y-o-Y Growth Projections by Component, 2022 to 2027
Figure 74: East Asia Market Attractiveness Analysis by Component, 2022 to 2027
Figure 75: East Asia Market Share and BPS Analysis by Product, 2022 & 2027
Figure 76: East Asia Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 77: East Asia Market Attractiveness Analysis by Product, 2022 to 2027
Figure 78: East Asia Market Share and BPS Analysis by End User, 2022 & 2027
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 80: East Asia Market Attractiveness Analysis by End User, 2022 to 2027
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2027
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2027
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2027
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Component, 2022 & 2027
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Component, 2022 to 2027
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Component, 2022 to 2027
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product, 2022 & 2027
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product, 2022 to 2027
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2022 & 2027
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2022 to 2027
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2027
Figure 101: MEA Market Share Analysis by Country, 2022 & 2027
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2027
Figure 104: MEA Market Share and BPS Analysis by Component, 2022 & 2027
Figure 105: MEA Market Y-o-Y Growth Projections by Component, 2022 to 2027
Figure 106: MEA Market Attractiveness Analysis by Component, 2022 to 2027
Figure 107: MEA Market Share and BPS Analysis by Product, 2022 & 2027
Figure 108: MEA Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 109: MEA Market Attractiveness Analysis by Product, 2022 to 2027
Figure 110: MEA Market Share and BPS Analysis by End User, 2022 & 2027
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 112: MEA Market Attractiveness Analysis by End User, 2022 to 2027
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current patient blood management market value?
In 2022, the global patient blood management market stands at US$ 12.7 billion.
What is the estimated market value of the patient blood management market?
The market for patient blood management is expected to reach US$ 18.4 billion by 2027.
What is the anticipated CAGR of the patient blood management market?
Over the next five years, demand for patient blood management is set to increase at 7.7% CAGR.
Which prime market players are profiled in this Fact.MR survey?
Immucor Inc., B. Braun Melsungen AG, Fresenius Se & Co. KGaA, Macopharma, Biomérieux SA, Asahi Kasei Medical Co. Ltd., F. Hoffmann-La Roche LTD., Terumo Corporation, Kaneka Corporation, and Abbott Laboratories are key market players.
How will the demand for patient blood management fare in China?
The China patient blood management market is predicted to expand at a CAGR of 10% and reach US$ 3.8 billion by the end of 2027.
Patient Blood Management Market